siRNA treatment reduces triglycerides in clients with rare health condition

.RESEARCH EMPHASIZE.19 September 2024.

Plozasiran decreased triglyceride amounts through 80% and also decreased the risk of pancreatitis in people with consistent chylomicronemia, with or even without a hereditary prognosis.